64,219 Shares in Ingevity Corporation $NGVT Acquired by Brandywine Global Investment Management LLC

Brandywine Global Investment Management LLC purchased a new stake in shares of Ingevity Corporation (NYSE:NGVT) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 64,219 shares of the company’s stock, valued at approximately $2,767,000. Brandywine Global Investment Management LLC owned approximately 0.18% of Ingevity at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S increased its position in shares of Ingevity by 21.6% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,670 shares of the company’s stock valued at $66,000 after acquiring an additional 297 shares during the period. Empowered Funds LLC lifted its holdings in Ingevity by 12.9% in the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after acquiring an additional 594 shares during the period. Keybank National Association OH purchased a new stake in Ingevity during the second quarter worth $206,000. Aristeia Capital L.L.C. acquired a new stake in Ingevity during the first quarter valued at $347,000. Finally, Inspire Investing LLC increased its stake in shares of Ingevity by 4.1% in the 2nd quarter. Inspire Investing LLC now owns 9,038 shares of the company’s stock valued at $389,000 after purchasing an additional 358 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Price Performance

Shares of NGVT stock opened at $50.93 on Tuesday. The firm’s 50-day moving average is $53.46 and its two-hundred day moving average is $49.68. Ingevity Corporation has a 12 month low of $28.49 and a 12 month high of $60.77. The company has a debt-to-equity ratio of 10.24, a current ratio of 1.36 and a quick ratio of 0.80. The company has a market capitalization of $1.83 billion, a PE ratio of -8.56 and a beta of 1.45.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Friday, March 24th. The company reported $0.78 EPS for the quarter. The firm had revenue of $336.00 million for the quarter. Ingevity had a positive return on equity of 84.92% and a negative net margin of 16.35%. Analysts predict that Ingevity Corporation will post 4.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on NGVT. BMO Capital Markets increased their target price on Ingevity from $62.00 to $68.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Wells Fargo & Company lifted their target price on shares of Ingevity from $52.00 to $55.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 12th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $61.50.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.